[Federal Register Volume 86, Number 66 (Thursday, April 8, 2021)]
[Notices]
[Page 18323]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-07245]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--R Consortium, Inc.

    Notice is hereby given that, on March 22, 2021, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), R Consortium, Inc. (``R 
Consortium'') has filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing changes in 
its membership. The notifications were filed for the purpose of 
extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, GlaxoSmithKline USA, Research Triangle Park, NC, has been 
added as a party to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and R Consortium intends to file 
additional written notifications disclosing all changes in membership.
    On September 15, 2015, R Consortium filed its original notification 
pursuant to Section 6(a) of the Act. The Department of Justice 
published a notice in the Federal Register pursuant to Section 6(b) of 
the Act on October 2, 2015 (80 FR 59815).
    The last notification was filed with the Department on December 28, 
2020. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on January 13, 2021 (86 FR 2698).

Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2021-07245 Filed 4-7-21; 8:45 am]
BILLING CODE 4410-11-P